id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-E-0073-0003,FDA,FDA-1998-E-0073,Letter from FDA Office of Health Affairs to the Honorable Bruce Lehman,Other,Letter(s),1998-12-15T05:00:00Z,1998,12,,,2025-03-05T17:58:55Z,,0,0,0900006480583e2c
FDA-1998-E-0073-0004,FDA,FDA-1998-E-0073,Letter from FDA Office of Health Affairs to the Honorable Bruce Lehman,Other,Letter(s),1998-12-15T05:00:00Z,1998,12,,,2025-03-05T18:00:43Z,,0,0,0900006480583e2f
FDA-1998-P-0084-0002,FDA,FDA-1998-P-0084,"Citizen Petition Approval from FDA CDER to AndrxPharmaceuticals, Inc.",Other,Approval,1998-12-09T05:00:00Z,1998,12,,,2024-07-17T16:02:24Z,,0,0,0900006480584d84
FDA-1995-S-0039-0058,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report,1998-11-28T05:00:00Z,1998,11,2008-10-06T04:00:00Z,,2016-09-30T14:22:28Z,,0,0,090000648055c389
FDA-1998-E-0073-0002,FDA,FDA-1998-E-0073,Letter from FDA Office of Health Affairs to U.S. Patent and Trademark Office,Other,Letter(s),1998-11-06T05:00:00Z,1998,11,,,2025-03-05T17:50:58Z,,0,0,0900006480583e2a
FDA-1998-E-0073-0001,FDA,FDA-1998-E-0073,Letter from FDA Office of Health Affairs to U.S. Patent and Trademark Office,Other,Letter(s),1998-11-06T05:00:00Z,1998,11,,,2025-03-05T17:49:53Z,,0,0,0900006480583dc4
FDA-1992-P-0047-0001,FDA,FDA-1992-P-0047,Denial Letter from FDA CDRH to Hyman Phelps & McNamara P.C.,Other,Denial of Petition,1998-09-02T04:00:00Z,1998,9,,,2024-11-07T18:49:27Z,,0,0,090000648052bc92
FDA-1980-N-0074-0064,FDA,FDA-1980-N-0074,HFA-305 to Kleinfeld Kaplan & Becker,Other,ACK-Acknowledgement Letter,1998-08-27T04:00:00Z,1998,8,,,2008-05-30T22:52:38Z,,0,0,09000064805bb491
FDA-1998-V-0065-0003,FDA,FDA-1998-V-0065,Acknowledgement Letter to Universal Studios Florida,Other,Acknowledgement Letter/Receipt,1998-08-18T04:00:00Z,1998,8,,,2012-01-26T02:41:16Z,,0,0,0900006480571c7d
FDA-1998-P-0016-0001,FDA,FDA-1998-P-0016,Acknowledgement Letter to Kenneth B. Lerman,Other,ACK-Acknowledgement Letter,1998-08-14T04:00:00Z,1998,8,,,2008-10-09T19:30:14Z,,0,0,09000064805639e6
FDA-1980-N-0074-0063,FDA,FDA-1980-N-0074,"HFD-560 to Hyman Phelps & McNamara, P. C.",Other,LET-Letter,1998-07-29T04:00:00Z,1998,7,,,2008-05-30T22:53:09Z,,0,0,09000064805bb48f
FDA-1998-P-0086-0001,FDA,FDA-1998-P-0086,Letter from FDA/CFSAN to Amway Corporation - Nutrilite Division,Other,Letter(s),1998-07-23T04:00:00Z,1998,7,,,2015-12-04T21:20:47Z,,0,0,09000064805850e3
FDA-1998-D-0102-0002,FDA,FDA-1998-D-0102,Guidance for Industry Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body,Other,Guidance,1998-06-12T04:00:00Z,1998,6,,,2024-11-07T21:53:55Z,,1,0,0900006480587376
FDA-1980-N-0067-0003,FDA,FDA-1980-N-0067,Letter from FDA CDER to Nonprescription Drug Manufacturers Association,Other,Letter(s),1998-06-09T04:00:00Z,1998,6,,,2022-06-06T15:15:58Z,,0,0,09000064805bb049
FDA-1997-P-0054-0001,FDA,FDA-1997-P-0054,"FDA/CDER Response to the Center for Positron Emission Tomography, State University of New York at Buffalo, Department of Nuclear Medicine, May 26, 1998 - Petition Approval",Other,PAV-Petition Approval,1998-06-01T04:00:00Z,1998,6,,,2013-08-11T04:24:37Z,,0,0,09000064805cfd12
FDA-1995-S-0039-0056,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report,1998-05-28T04:00:00Z,1998,5,2008-10-06T04:00:00Z,,2016-09-30T14:22:27Z,,0,0,090000648055c385
FDA-1996-P-0246-0019,FDA,FDA-1996-P-0246,Memorandum of Meeting Between FDA CFSAN Meeting With National Confectioners Association (NCA) and Chocolate Manufacturers Association (CMA) May 6 1998,Other,Memorandum,1998-05-22T04:00:00Z,1998,5,2014-02-20T05:00:00Z,,2014-02-20T14:21:04Z,,0,0,090000648050397e
FDA-1996-P-0309-0019,FDA,FDA-1996-P-0309,"Memorandum of Meeting Between FDA/CFSAN and Chocolate Manufacturers Association (CMA) and the National Confectioners Association (NCA) May 6, 1998",Other,Memorandum,1998-05-22T04:00:00Z,1998,5,2014-02-20T05:00:00Z,,2014-02-20T12:34:11Z,,0,0,0900006480504c8a
FDA-1979-N-0028-0012,FDA,FDA-1979-N-0028,"Memorandum of Telephone Conversation Dated January 29, 1997",Other,Memorandum,1998-05-15T04:00:00Z,1998,5,,,2014-05-14T15:45:57Z,,0,0,090000648055399e
FDA-1979-N-0028-0010,FDA,FDA-1979-N-0028,"Memorandum of Telephone Conversation Dated December 23, 1996",Other,Memorandum,1998-05-15T04:00:00Z,1998,5,,,2014-05-14T15:40:40Z,,0,0,090000648055399c
FDA-1979-N-0028-0011,FDA,FDA-1979-N-0028,"Memorandum of Telephone Conversation Dated January 10, 1997",Other,Memorandum,1998-05-15T04:00:00Z,1998,5,,,2014-05-14T15:42:52Z,,0,0,090000648055399d
FDA-1986-V-0024-0001,FDA,FDA-1986-V-0024,Lasertainment Productions Int - Approval for Variance,Other,VRA-Approval for Variance,1998-05-06T04:00:00Z,1998,5,,,2013-08-11T04:14:18Z,,0,0,090000648050df6a
FDA-1995-S-0039-0065,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report,1998-04-30T04:00:00Z,1998,4,2008-10-06T04:00:00Z,,2016-09-30T14:22:30Z,,0,0,0900006480738cc4
FDA-1979-N-0028-0009,FDA,FDA-1979-N-0028,Memorandum from FDA RE: Sun Chemical Corporation,Other,Memorandum,1998-04-17T04:00:00Z,1998,4,,,2014-05-14T15:37:31Z,,0,0,090000648055399a
FDA-1995-S-0039-0040,FDA,FDA-1995-S-0039,"Supplement from FDA/CFSAN to Douglas D. Lazarus, Ph. D.",Other,SUP-Supplement,1998-04-14T04:00:00Z,1998,4,2008-09-28T04:00:00Z,,2016-09-30T14:19:50Z,,0,0,090000648055c338
FDA-1987-N-0025-0019,FDA,FDA-1987-N-0025,"HFA-305 to Judith H. Johnsrud, Ph.D.",Other,ACK-Acknowledgement Letter,1998-04-14T04:00:00Z,1998,4,,,2008-05-30T22:53:07Z,,0,0,090000648046c269
FDA-1998-P-0084-0001,FDA,FDA-1998-P-0084,"Acknowledgment Letter from FDA DMB to Andrx Pharmaceuticals, Inc",Other,Acknowledgement Letter/Receipt,1998-04-10T04:00:00Z,1998,4,,,2024-07-17T16:00:34Z,,0,0,0900006480584d22
FDA-1995-S-0039-0051,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report,1998-04-09T04:00:00Z,1998,4,2008-10-06T04:00:00Z,,2016-09-30T14:22:25Z,,0,0,090000648055c37b
FDA-1995-S-0039-0045,FDA,FDA-1995-S-0039,Report from FDA/CFSAN,Other,RPT-Report,1998-04-09T04:00:00Z,1998,4,2008-09-30T04:00:00Z,,2016-09-30T14:19:52Z,,0,0,090000648055c374
FDA-1998-P-0015-0001,FDA,FDA-1998-P-0015,"Acknowledgement Letter  toFarm Sanctuary Inc. (Goodin, MacBride, Squeri, Schlotz & Ritchie, LLP)",Other,ACK-Acknowledgement Letter,1998-03-05T05:00:00Z,1998,3,,,2011-04-19T15:55:09Z,,0,0,090000648055af5e
FDA-2020-D-1961-0001,FDA,FDA-2020-D-1961,Guidance for Industry: Guide for Developing and Using Data Bases for Nutrition Labeling,Other,Guidance,1998-03-01T05:00:00Z,1998,3,2020-09-21T04:00:00Z,,2024-11-12T23:24:59Z,,1,0,090000648486939b
FDA-1996-P-0246-0009,FDA,FDA-1996-P-0246,Request for Extension from Chocolate Manufacturers Association (CMA) and National Confectioners Association (NCA),Other,Request for Extension,1998-02-20T05:00:00Z,1998,2,2014-02-20T05:00:00Z,,2014-02-20T13:50:33Z,,0,0,0900006480503977
FDA-1996-P-0309-0007,FDA,FDA-1996-P-0309,Request for Extension of the Comment Due Date from Chocolate Manufacturers Association (CMA) and the National Confectioners Association (NCA),Other,Request for Extension,1998-02-20T05:00:00Z,1998,2,2014-02-20T05:00:00Z,,2014-02-20T12:18:00Z,,0,0,0900006480504c7b
FDA-1998-A-0109-0001,FDA,FDA-1998-A-0109,Acknowledgment Letter from FDA Dockets Management Branch to International Dairy Foods Association,Other,Acknowledgement Letter/Receipt,1998-02-13T05:00:00Z,1998,2,,,2025-01-31T02:01:04Z,,0,0,0900006480588172
FDA-1980-N-0074-0062,FDA,FDA-1980-N-0074,"FDA/ORA to The Cosmetic, Toiletry & Fragrance Association",Other,PDN-Petition Denial,1998-02-06T05:00:00Z,1998,2,,,2008-05-30T22:52:25Z,,0,0,09000064805bb48e
FDA-1998-P-0086-0006,FDA,FDA-1998-P-0086,Acknowledgement Letter from FDA/DDM to Amyway Corporation -Nutrilite Division,Other,ACK-Acknowledgement Letter,1998-01-23T05:00:00Z,1998,1,,,2015-12-04T20:01:17Z,,0,0,0900006480585164